Mouse or man? Which are pertussis vaccines to protect?
- 1 April 1976
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 76 (2), 249-256
- https://doi.org/10.1017/s0022172400055145
Abstract
SUMMARY: Type 1 strains ofBordetella pertussiscan infect mouse brain and have been recovered as type 1 organisms after death. When introduced into the naso-pharynx of the marmoset, they immediately acquired agglutinogen 2 or 3, and the resulting type 1,2 or 1,3 infection persisted for many weeks.As in the child, agglutinogens 2 and/or 3 appear to be essential for infection of the marmoset, whereas they are quite unnecessary in mouse brain. A vaccine (extract or whole cell) containing agglutinogen 1 may be sufficient to pass the mouse protection test but it may fail to immunize children. The mouse test is inadequate even for the screening of such extracts.This publication has 24 references indexed in Scilit:
- Variation of serotype in strains of Bordetella pertussisEpidemiology and Infection, 1974
- Experimental pertussis infection in the marmoset: type specificity of active immunityEpidemiology and Infection, 1974
- Pertussis antibodies in the sera of children exposed toBordetella pertussisby vaccination or infectionEpidemiology and Infection, 1973
- Efficacy of Pertussis Vaccines: A Brighter HorizonBMJ, 1972
- Vaccination against whooping-cough.BMJ, 1969
- Variation in Bordetella pertussisThe Journal of Pathology and Bacteriology, 1967
- Type-specific Immunity against Intracerebral Pertussis Infection in MiceNature, 1963
- The relation between agglutinin production by pertussis vaccines and their immunising potency in miceThe Journal of Pathology and Bacteriology, 1959
- PROTECTIVE ANTIGEN OF HÆMOPHILUS PERTUSSISThe Lancet, 1954
- SOME OBSERVATIONS MADE DURING EXPERIMENTS ON MICE INOCULATED WITH H. PERTUSSIS.Acta Pathologica Microbiologica Scandinavica, 1952